Head and Neck Squamous Cell Carcinoma (HNSCC)
Head and Neck Squamous Cell Carcinoma (HNSCC) is a type of cancer that arises in the squamous cells lining the head and neck, often associated with risk factors like tobacco use and HPV infection.
We are studying whether combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 can help people with head and neck or liver cancer. This research aims to find more effective treatment options.
Health conditions and diseases that the clinical trial is designed to study and treat.
Head and Neck Squamous Cell Carcinoma (HNSCC) is a type of cancer that arises in the squamous cells lining the head and neck, often associated with risk factors like tobacco use and HPV infection.
Hepatocellular Carcinoma (HCC) is a rare type of liver cancer that typically occurs in individuals with chronic liver diseases, such as cirrhosis or hepatitis.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.